News

News

New £50m venture capital fund will give a shot in the arm to UK life sciences

News

Scotland’s TCB inks CAR-T deal with Japan’s NIPRO

News

Acerus Enters into a Licensing Agreement with Viramal to Commercialize the Elegant™ Franchise in Canada

News

bluebird bio and TC BioPharm Announce Strategic Collaboration to Research and Develop Gamma Delta CAR T Cell Product Candidates for Cancer Immunotherapy

News

Age of Discovery (PharmaTimes, November 2017)

News

NCL Innovation Leads Second Round of investment in Coomtech Ltd

News

FutureNova FlipPad – Media Coverage in March 2017

News

NCL Innovation leads equity investment round into ‘game-changing’ technology destined to save thousands of lives through real time detection of airborne asbestos

News

Kent based sterile technology company FutureNova enjoys international success with first US sales with plans to scale up manufacturing to meet market demand from the health sector

News

Discovery Park Technology Fund invests in pioneering clinical development company, TC BioPharm (TCB) providing a launchpad for clinical trials of new treatments for cancer and viral infections